References
- GothwalVKWrightTALamoureuxELPesudovsKMeasuring outcomes of cataract surgery using the Visual Function Index-14J Cataract Refract Surg20103671181118820610098
- PesudovsKPatient-centred measurement in ophthalmology-a paradigm shiftBMC Ophthalmol200662516774690
- PesudovsKGothwalVKWrightTLamoureuxELRemediating serious flaws in the National Eye Institute Visual Function QuestionnaireJ Cataract Refract Surg201036571873220457362
- PetrilloJBresslerNMLamoureuxEFerreiraACanoSDevelopment of a new Rasch-based scoring algorithm for the National Eye Institute Visual Functioning Questionnaire to improve its interpretabilityHealth Qual Life Outcomes201715115728807029
- McalindenCSkiadaresiEMooreJPesudovsKSubscale assessment of the NEI-RQL-42 questionnaire with Rasch analysisInvest Opthalmol Vis Sci201152856855694
- DeanSMathersJMCalvertM“The patient is speaking”: discovering the patient voice in ophthalmologyBr J Ophthalmol2017101670070828455280
- LamoureuxELMcintoshRConstantinouMComparing the effectiveness of selective laser trabeculoplasty with topical medication as initial treatment (the Glaucoma Initial Treatment Study): study protocol for a randomised controlled trialTrials20151640626362541
- GazzardGKonstantakopoulouEGarway-HeathDLaser in Glaucoma and Ocular Hypertension (LiGHT) trial. A multicentre, randomised controlled trial: design and methodologyBr J Ophthalmol2018102559359828903966
- StelmackJATangXCRedaDJOutcomes of the Veterans Affairs Low Vision Intervention Trial (LOVIT)Arch Ophthalmol2008126560861718474769
- StelmackJATangXCWeiYOutcomes of the Veterans Affairs Low Vision Intervention Trial II (LOVIT II): a randomized clinical trialJAMA Ophthalmol Epub20161215
- DawsonJDollHFitzpatrickRJenkinsonCCarrAJThe routine use of patient reported outcome measures in health care settingsBMJ2010340c18620083546
- NelsonECEftimovskaELindCHagerAWassonJHLindbladSPatient reported outcome measures in practiceBMJ2015350g781825670183
- MassofRWThe measurement of vision disabilityOptom Vis Sci200279851655212199545
- MichelottiMde KorneDFWeizerJSMapping standard ophthalmic outcome sets to metrics currently reported in eight eye hospitalsBMC Ophthalmol201717126929284445
- HartPMChakravarthyUStevensonMRQuestionnaire-based survey on the importance of quality of life measures in ophthalmic practiceEye199812Pt 11241269614528
- MassofRWRubinGSVisual function assessment questionnairesSurv Ophthalmol200145653154811425359
- KhadkaJFenwickELamoureuxEPesudovsKMethods to develop the eye-tem bank to measure ophthalmic quality of lifeOptom Vis Sci201693121485149427668638
- LundströmMPesudovsKQuestionnaires for measuring cataract surgery outcomesJ Cataract Refract Surg201137594595921511158
- PetrilloJCanoSJMcleodLDCoonCDUsing classical test theory, item response theory, and Rasch measurement theory to evaluate patient-reported outcome measures: a comparison of worked examplesValue Health2015181253425595231
- TerweeCBBotSDde BoerMRQuality criteria were proposed for measurement properties of health status questionnairesJ Clin Epidemiol2007601344217161752
- de BoerMRMollACde VetHCTerweeCBVölker-DiebenHJvan RensGHPsychometric properties of vision-related quality of life questionnaires: a systematic reviewOphthalmic Physiol Opt200424425727315228503
- PesudovsKBurrJMHarleyCElliottDBThe development, assessment, and selection of questionnairesOptom Vis Sci200784866367417700331
- US Department of Health and Human Services FaDAFGuidance for Industry: Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labelling Claims2009 Available from: http://www.fda.gov/downloads/Drugs/Guidances/UCM193282.pdfAccessed September 25, 2018
- Prem SenthilMKhadkaJPesudovsKAssessment of patient-reported outcomes in retinal diseases: a systematic reviewSurv Ophthalmol201762454658228062197
- EuroQol GroupEuroQol-a new facility for the measurement of health-related quality of lifeHealth Policy199016319920810109801
- HerdmanMGudexCLloydADevelopment and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)Qual Life Res201120101727173621479777
- YangYRowenDBrazierJTsuchiyaAYoungTLongworthLAn exploratory study to test the impact on three “bolt-on” items to the EQ-5DValue Health2015181526025595234
- DolanPModeling valuations for EuroQol health statesMed Care19973511109511089366889
- BernertSFernándezAHaroJMComparison of different valuation methods for population health status measured by the EQ-5D in three European countriesValue Health200912575075819490564
- DevlinNJShahKKFengYMulhernBvan HoutBValuing health-related quality of life: An EQ-5D-5L value set for EnglandHealth Econ201827172228833869
- WaltersSJBrazierJEComparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6DQual Life Res20051461523153216110932
- BrazierJUsherwoodTHarperRThomasKDeriving a preference-based single index from the UK SF-36 Health SurveyJ Clin Epidemiol19985111111511289817129
- WareJESherbourneCDThe MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selectionMed Care19923064734831593914
- BrazierJRobertsJDeverillMThe estimation of a preference-based measure of health from the SF-36J Health Econ200221227129211939242
- TorranceGWMeasurement of health state utilities for economic appraisalJ Health Econ19865113010311607
- HorsmanJFurlongWFeenyDTorranceGThe Health Utilities Index (HUI): concepts, measurement properties and applicationsHealth Qual Life Outcomes200315414613568
- FurlongWFDTorranceGWGoldsmithCMultiplicative Multi-Attribute Utility Function for the Helth Utilities Indiex Mark 3 (HUI3) System: A Technical ReportHamilton, Ontario, CanadaMcMaster University1998
- BrazierJRobertsJTsuchiyaABusschbachJA comparison of the EQ-5D and SF-6D across seven patient groupsHealth Econ200413987388415362179
- ToshJCLongworthLJGeorgeEUtility values in National Institute for Health and Clinical Excellence (NICE) Technology AppraisalsValue Health201114110210921211492
- BilbaoAQuintanaJMEscobarAResponsiveness and clinically important differences for the VF-14 index, SF-36, and visual acuity in patients undergoing cataract surgeryOphthalmology2009116341842419168220
- IjzermanMJKoffijbergHFenwickEKrahnMEmerging use of early health technology assessment in medical product development: a scoping review of the literaturePharmacoeconomics201735772774028432642
- BassEBMarshMJMangioneCMPatients’ perceptions of the value of current vision: assessment of preference values among patients with subfoveal choroidal neovascularization-The Submacular Surgery Trials Vision Preference Value Scale: SST Report No. 6Arch Ophthalmol2004122121856186715596591
- KymesSMLeeBSPreference-based quality of life measures in people with visual impairmentOptom Vis Sci200784880981617700344
- MokkinkLBTerweeCBKnolDLThe COSMIN checklist for evaluating the methodological quality of studies on measurement properties: a clarification of its contentBMC Med Res Methodol2010102220298572
- KhadkaJMcAlindenCPesudovsKQuality assessment of ophthalmic questionnaires: review and recommendationsOptom Vis Sci201390872074423873034
- FenwickEKManREReesGKeeffeJWongTYLamoureuxELReducing respondent burden: validation of the Brief Impact of Vision Impairment questionnaireQual Life Res201726247948827558785
- VandenbroeckSde GeestSZeyenTStalmansIDobbelsFPatient-reported outcomes (PRO’s) in glaucoma: a systematic reviewEye201125555557721423144
- Che HamzahJBurrJMRamsayCRAzuara-BlancoAPriorMChoosing appropriate patient-reported outcomes instrument for glaucoma research: a systematic review of vision instrumentsQual Life Res20112071141115821203852
- KhadkaJMcAlindenCCraigJEFenwickEKLamoureuxELPesudovsKIdentifying content for the glaucoma-specific item bank to measure quality-of-life parametersJ Glaucoma2015241121923552836
- LeJTViswanathanSTarverMEEydelmanMLiTAssessment of the incorporation of patient-centric outcomes in studies of minimally invasive glaucoma surgical devicesJAMA Ophthalmol201613491054105627389667
- KingAJFernieGAzuara-BlancoATreatment of advanced glaucoma study: a multicentre randomised controlled trial comparing primary medical treatment with primary trabeculectomy for people with newly diagnosed advanced glaucoma-study protocolBr J Ophthalmol2018102792292829074496
- Prem SenthilMKhadkaJGilhotraJSSimonSPesudovsKExploring the quality of life issues in people with retinal diseases: a qualitative studyJ Patient Rep Outcomes2017111529757297
- Prem SenthilMKhadkaJde RoachJDeveloping an item bank to measure the coping strategies of people with hereditary retinal diseasesGraefes Arch Clin Exp Ophthalmol201825671291129829730797
- DennistonAKHollandGNKidessAHeterogeneity of primary outcome measures used in clinical trials of treatments for intermediate, posterior, and panuveitisOrphanet J Rare Dis2015109726286265
- TallouziMOMathersJMMooreDJCOSUMO: study protocol for the development of a core outcome set for efficacy and effectiveness trials in posterior segment-involving uveitisTrials201718157629191216
- HatemiGMearaAOzgulerYDeveloping a Core Set of Outcome Measures for Behçet Disease: Report from OMERACT 2016J Rheumatol201744111750175328365574
- HeiligenhausAFoeldvariIEdelstenCProposed outcome measures for prospective clinical trials in juvenile idiopathic arthritis-associated uveitis: a consensus effort from the multinational interdisciplinary working group for uveitis in childhoodArthritis Care Res201264913651372
- HolbrookJTKempenJHPrusakowskiNAAltaweelMMJabsDAMulticenter Uveitis Steroid Treatment (MUST) Trial Research GroupChallenges in the design and implementation of the Multicenter Uveitis Steroid Treatment (MUST) Trial-lessons for comparative effectiveness trialsClin Trials20118673674321994128
- KrezelAKHoggREAzuara-BlancoAPatient-reported outcomes in randomised controlled trials on age-related macular degenerationBr J Ophthalmol201599111560156425934846
- RodriguesIASprinkhuizenSMBarthelmesDDefining a minimum set of standardized patient-centered outcome measures for macular degenerationAm J Ophthalmol201616811227131774
- FingerRPSchmitz-ValckenbergSSchmidMMACUSTAR: Development and clinical validation of functional, structural, and patient-reported endpoints in intermediate age-related macular degenerationOphthalmologica Epub2018828
- ButtTTufailARubinGHealth state utility values for age-related macular degeneration: review and adviceAppl Health Econ Health Policy2017151233227637920
- Writing Team for the DCCT/EDIC Research GroupGubitosi-KlugRASunWEffects of prior intensive insulin therapy and risk factors on patient-reported visual function outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) CohortJAMA Ophthalmol2016134213714526584339
- FenwickEKPesudovsKReesGThe impact of diabetic reti-nopathy: understanding the patient’s perspectiveBr J Ophthalmol201195677478220940313
- FenwickEReesGPesudovsKSocial and emotional impact of diabetic retinopathy: a reviewClin Exp Ophthalmol2012401273821575125
- FenwickEKPesudovsKKhadkaJReesGWongTYLamoureuxELEvaluation of item candidates for a diabetic retinopathy quality of life item bankQual Life Res20132271851185823135924
- FenwickEKPesudovsKKhadkaJThe impact of diabetic retinopathy on quality of life: qualitative findings from an item bank development projectQual Life Res201221101771178222290480
- FenwickEKKhadkaJPesudovsKReesGWongTYLamoureuxELDiabetic retinopathy and macular edema quality-of-life item banks: development and initial evaluation using computerized adaptive testingInvest Ophthalmol Vis Sci201758146379638729260195
- Macular Degeneration Appendix H: GRADE tables and meta-analysis results2018 Available from: http://www.nice.org.uk/guidance/ng82/evidence/appendix-h-grade-tables-and-metaanalysis-results-pdf-4723229205
- McAlindenCGothwalVKKhadkaJWrightTALamoureuxELPesudovsKA head-to-head comparison of 16 cataract surgery outcome questionnairesOphthalmology2011118122374238121945088
- MahmudIKelleyTStowellCA proposed minimum standard set of outcome measures for cataract surgeryJAMA Ophthalmol2015133111247125226291752
- DayACBurrJMBunceCRandomised, single-masked non-inferiority trial of femtosecond laser-assisted versus manual phacoemulsification cataract surgery for adults with visually significant cataract: the FACT trial protocolBMJ Open2015511e010381
- SparrowJMGrzedaMTFrostNACataract surgery patient-reported outcome measures: a head-to-head comparison of the psychometric performance and patient acceptability of the Cat-PROM5 and Catquest-9SF self-report questionnairesEye201832478879529386619
- KumaranSEKhadkaJBakerRPesudovsKPatient-reported outcome measures in amblyopia and strabismus: a systematic reviewClin Exp Optom2017
- LeskeDAHattSRLiebermannLHolmesJMEvaluation of the adult Strabismus-20 (AS-20) questionnaire using Rasch analysisInvest Opthalmol Vis Sci201253626302639
- HattSRLeskeDALiebermannLHolmesJMIncorporating health-related quality of life into the assessment of outcome following strabismus surgeryAm J Ophthalmol20161641526747379
- TadićVHoganASobtiNKnowlesRLRahiJSPatient-reported outcome measures (PROMs) in paediatric ophthalmology: a systematic reviewBr J Ophthalmol201397111369138123743433
- TadićVRahiJSOne size doesn’t fit all: time to revisit patient-reported outcome measures (PROMs) in paediatric ophthalmology?Eye201731451151828085146
- HattSRLeskeDACastanedaYSPatient-derived questionnaire items for patient-reported outcome measures in pediatric eye conditionsJ AAPOS2018226445448.e2230243933
- SchulzCBKennedyARogersSA Systematic Review of Patient-Reported Outcomes for Surgically Amenable EpiphoraOphthalmic Plast Reconstr Surg201834319320029737972
- LacknerAFicjanAStradnerMHIt’s more than dryness and fatigue: the patient perspective on health-related quality of life in primary Sjögren’s syndrome – A qualitative studyPLoS One2017122e017205628182787
- LacknerAStradnerMHHermannJAssessing health-related quality of life in primary Sjögren’s syndrome-The PSS-QoLSemin Arthritis Rheum201848110511029395257
- CornecDDevauchelle-PensecVMarietteXSevere health-related quality of life impairment in active primary Sjögren’s syndrome and patient-reported outcomes: data from a large therapeutic trialArthritis Care Res2017694528535
- GuilleminIBegleyCChalmersRBaudouinCArnouldBAppraisal of patient-reported outcome instruments available for randomized clinical trials in dry eye: revisiting the standardsOcul Surf2012102849922482469
- NobleBALohRSMacLennanSComparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface diseaseBr J Ophthalmol200488564765215090417
- ClaessonMArmitageWJByströmBValidation of Cat-quest-9SF-A visual disability instrument to evaluate patient function after corneal transplantationCornea20173691083108828777777
- KandelHKhadkaJLundströmMGogginMPesudovsKQuestionnaires for measuring refractive surgery outcomesJ Refract Surg201733641642428586503
- KandelHKhadkaJFenwickEKConstructing item banks for measuring quality of life in refractive errorOptom Vis Sci201895757558729957741
- BradyCJVillantiACGandhiMFriedmanDSKeayLVisual function after correction of distance refractive error with ready-made and custom spectacles: a randomized clinical trialOphthalmology2012119102014202022705346
- RameyNAButtZBurkatCNRoseJGLucarelliMJPatient-reported outcomes: comprehensive analysis for the oculofacial clinicianOphthalmic Plast Reconstr Surg201430427928924814273
- KlassenAFCanoSJGrottingJCFACE-Q Eye module for measuring patient-reported outcomes following cosmetic eye treatmentsJAMA Facial Plast Surg201719171427631534
- LongmireNMWong RiffKWYO’HaraJLDevelopment of a new module of the FACE-Q for children and young adults with diverse conditions associated with visible and/or functional facial differencesFacial Plast Surg201733549950828962056
- HepworthLRRoweFJHarperRJarvisKShipmanTRodgersHPatient reported outcome measures for visual impairment after stroke: a systematic reviewHealth Qual Life Outcomes20151314626374628
- RaphaelBAGalettaKMJacobsDAValidation and test characteristics of a 10-item neuro-ophthalmic supplement to the NEI-VFQ-25Am J Ophthalmol200614261026103517046704
- PiperRJKalyvasAVYoungAMHughesMAJamjoomAAFouyasIPInterventions for idiopathic intracranial hypertensionCochrane Database Syst Rev20158CD003434
- MerkerVLBergnerALVranceanuAMMuzikanskyASlatteryWPlotkinSRHealth-related quality of life of individuals with neurofibromatosis type 2: results from the NF2 natural history studyOtol Neurotol201637557457927050651
- MoorePJacksonCMutchKPatient-reported outcome measure for neuromyelitis optica: pretesting of preliminary instrument and protocol for further development in accordance with international guidelinesBMJ Open201669e011142
- MethleyAMMutchKMoorePJacobADevelopment of a patientcentred conceptual framework of health-related quality of life in neuromyelitis optica: a qualitative studyHealth Expect2017201475826599425
- Talaei-KhoeiMRiklinEMerkerVLFirst use of patient reported outcomes measurement information system (PROMIS) measures in adults with neurofibromatosisJ Neurooncol2017131241341927900643
- EhrlichJRSpaethGLCarlozziNELeePPPatient-centered outcome measures to assess functioning in randomized controlled trials of low-vision rehabilitation: a reviewPatient2017101394927495171
- LundströmMSteneviUThorburnWQuality of life after first- and second-eye cataract surgery: five-year data collected by the Swedish national cataract registerJ Cataract Refract Surg200127101553155911687351
- Stolk-VosACVisserMSKlijnSEffects of clinical parameters on patient-reported outcome in cataract patients: a multicentre studyActa Ophthalmol201896658659129575507
- MollazadeganKLundströmMA study of the correlation between patient-reported outcomes and clinical outcomes after cataract surgery in ophthalmic clinicsActa Ophthalmol201593329329824975543
- HeeOKThngZXZhuHYLamoureuxELUsage of glaucoma-specific patient-reported outcome measures (PROMs) in the Singapore context: a qualitative scoping exerciseBMC Ophthalmol201818119730107834
- SladeAIsaFKyteDPatient reported outcome measures in rare diseases: a narrative reviewOrphanet J Rare Dis20181316129688860
- PesudovsKItem banking: a generational change in patient-reported outcome measurementOptom Vis Sci201087428529320142792
- CalvertMKyteDMercieca-BebberRGuidelines for inclusion of patient-reported outcomes in clinical trial protocolsJAMA2018319548349429411037
- BottomleyAPeMSloanJMoving forward toward standardizing analysis of quality of life data in randomized cancer clinical trialsClin Trials201815662463030141714
- Cruz RiveraSKyteDGAiyegbusiOLKeeleyTJCalvertMJAssessing the impact of health care research: a systematic review of methodological frameworksPLoS Med2017148e100237028792957
- KotechaAFeuerWJBartonKGeddeSJTube Versus Trabeculectomy Study GroupQuality of life in the tube versus Trabeculectomy StudyAm J Ophthalmol201717622823528161049
- SkalickySED’MellowGHousePFenwickEGlaucoma Australia Educational Impact Study ContributorsGlaucoma Australia educational impact study: a randomized short-term clinical trial evaluating the association between glaucoma education and patient knowledge, anxiety and treatment satisfactionClin Exp Ophthalmol201846322223128691363
- BengtssonBHeijlAJohannessonGAndersson-GeimerSAspbergJLindénCThe Glaucoma Intensive Treatment Study (GITS), a randomized clinical trial: design, methodology and baseline dataActa Ophthalmologica201896655756630171664
- GohDde KorneDFHoHShared cared for stable glaucoma patients: economic benefits and patient-centered outcomes of a feasibility trialJ Glaucoma201827217017529271805
- SheppardJJoshiABettsKAEffect of Adalimumab on visual functioning in patients with noninfectious intermediate uveitis, posterior uveitis, and panuveitis in the VISUAL-1 and VISUAL-2 trialsJAMA Ophthalmology2017135651151828426849
- LescrauwaetBMiserocchiEThurauSAssociation between visual function response and reduction of inflammation in noninfectious uveitis of the posterior segmentInvest Opthalmol Vis Sci201758935553562
- NiemeyerKMGonzalesJARathinamSRQuality-of-life outcomes from a randomized clinical trial comparing antimetabolites for intermediate, posterior, and panuveitisAm J Ophthalmol2017179101728414043
- NaikRKRentzAMFosterCSNormative comparison of patient-reported outcomes in patients with noninfectious uveitisJAMA Ophthalmology2013131221922523411886
- BresslerNMChangTSSuñerIJVision-related function after ranibizumab treatment by better- or worse-seeing eye: clinical trial results from MARINA and ANCHOROphthalmology2010117474775620189654
- ScottIUFigueroaMJOdenNLSCORE2 Report 5: vision-related function in patients with macular edema secondary to central retinal or hemiretinal vein occlusionAm J Ophthalmol201718414715629074161
- RamuJChatziralliIYangYHealth-related quality of life, visual function and treatment satisfaction following intravitreal dexamethasone implant for diabetic macular edemaPatient Prefer Adherence20171157958628360511
- ChakravarthyUHardingSPRogersCAA randomised controlled trial to assess the clinical effectiveness and cost-effectiveness of alternative treatments to Inhibit VEGF in age-related choroidal neovascularisation (IVAN)Health Technol Assess201519781298
- BresslerNMVarmaRSunerIJVision-related function after ranibizumab treatment for diabetic macular edema: results from RIDE and RISEOphthalmology2014121122461247225148789
- MitchellPMassinPBresslerSThree-year patient-reported visual function outcomes in diabetic macular edema managed with ranibizumab: the RESTORE extension studyCurr Med Res Opin201531111967197526327116
- GilliesMCLimLLCampainAA randomized clinical trial of intravitreal bevacizumab versus intravitreal dexamethasone for diabetic macular edema: the BEVORDEX studyOphthalmology2014121122473248125155371
- LoftusJVSultanMBPleilAMChanges in vision- and health-related quality of life in patients with diabetic macular edema treated with pegaptanib sodium or shamInvest Opthalmol Vis Sci2011521074987505
- VarmaRBresslerNMSuñerIImproved vision-related function after ranibizumab for macular edema after retinal vein occlusion: results from the BRAVO and CRUISE trialsOphthalmology2012119102108211822817833